A Study of Oral Contraception Under Simulated OTC Conditions (OPTION)
A Multi-Center Oral Contraceptive Pill Use Trial Conducted In an OTC Naturalistic Environment (OPTION)
Sponsor: HRA Pharma
Terminated
Terminated prematurely due to issues with one of the data collection systems, no impact on subject safety
Other terminated trials from HRA Pharma
Other Contraception trials with similar outcome
Listed as NCT03559010, this PHASE3 trial focuses on Contraception and remains terminated or withdrawn. Sponsored by HRA Pharma, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
May 2022 — Jul 2024 [monthly]
Terminated PHASE3
-
Apr 2022 — May 2022 [monthly]
Terminated PHASE3
-
Dec 2021 — Apr 2022 [monthly]
Terminated PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Aug 2019 — Nov 2020 [monthly]
Terminated PHASE3
-
Mar 2019 — Aug 2019 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
-
Sep 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting PHASE3
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- HRA Pharma
For direct contact, visit the study record on ClinicalTrials.gov .